Nano-Ghosts: Biomimetic membranal vesicles, technology and characterization

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Traditional nano-carriers face challenges like immunogenicity and the EPR effect, hindering clinical translation.
• Biomimetic nano-vesicles (BNVs) are promising alternatives but suffer from production and loading inefficiencies.
• Existing BNVs face scalability issues, inconsistent manufacturing, and poor drug loading.

Purpose of the Study:

• To present a refined process for producing biomimetic nano-vesicles (BNVs) called Nano-Ghosts (NGs).
• To demonstrate the versatility and robustness of the NG technology for drug delivery applications.
• To highlight the potential of NGs for overcoming current limitations in nano-carrier development and facilitating clinical translation.

Main Methods:

• Production of NGs using mesenchymal stem cell membranes via sonication or extrusion.
• Labeling of NGs using fluorescence, radiolabeling, and genetic engineering for tracking.
• Enhanced therapeutic loading into NGs through electroporation for various drug types.

Main Results:

• Flexible and reproducible NG production using different physical methods.
• Successful multi-modal labeling of NGs for diagnostic and tracking purposes.
• Significantly improved loading efficiency for small molecules, peptides, and DNA via electroporation.

Conclusions:

• NGs offer a robust, versatile, and scalable platform for drug delivery.
• The NG technology addresses key limitations of current BNVs, showing strong potential for clinical application.
• NGs represent a significant advancement in nano-carrier development for anti-cancer therapeutics.